Posts Tagged ‘SHIFT trial’

April 17th, 2014

FDA Grants Fast Track Status to Ivabradine

Amgen announced yesterday that its new chronic heart failure drug ivabradine had been granted fast track status by the FDA. The company said the fast track designation, which is for drugs that treat serious conditions and fill an unmet medical need, will aid the development and speed the review of the drug. The company said it planned to file […]